Anti-tuberculosis treatment strategies and drug development: challenges and priorities

VA Dartois, EJ Rubin - Nature Reviews Microbiology, 2022 - nature.com
Despite two decades of intensified research to understand and cure tuberculosis disease,
biological uncertainties remain and hamper progress. However, owing to collaborative …

New developments in tuberculosis diagnosis and treatment

CM Gill, L Dolan, LM Piggott, AM McLaughlin - Breathe, 2022 - Eur Respiratory Soc
Tuberculosis (TB) is a major cause of morbidity and mortality worldwide. It is estimated that
25% of the world's population are infected with Mycobacterium tuberculosis, with a 5–10 …

[HTML][HTML] The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive …

D Goletti, G Delogu, A Matteelli, GB Migliori - International Journal of …, 2022 - Elsevier
ABSTRACT Objectives The World Health Organization estimated that a quarter of the global
population is infected by Mycobacterium tuberculosis (Mtb). A better control of tuberculosis …

[HTML][HTML] The definition of tuberculosis infection based on the spectrum of tuberculosis disease

GB Migliori, CWM Ong, L Petrone, L D'Ambrosio… - Breathe, 2021 - Eur Respiratory Soc
Latent tuberculosis infection was the term traditionally used to indicate tuberculosis (TB)
infection. This term was used to define “a state of persistent immune response to stimulation …

Diagnostic biomarkers for active tuberculosis: progress and challenges

BMF Nogueira, S Krishnan… - EMBO Molecular …, 2022 - embopress.org
Tuberculosis (TB) is a leading cause of morbidity and mortality from a single infectious
agent, despite being preventable and curable. Early and accurate diagnosis of active TB is …

Clinical standards for the diagnosis, treatment and prevention of TB infection

GB Migliori, SJ Wu, A Matteelli, D Zenner… - … of Tuberculosis and …, 2022 - ingentaconnect.com
BACKGROUND: Tuberculosis (TB) preventive therapy (TPT) decreases the risk of
develo** TB disease and its associated morbidity and mortality. The aim of these clinical …

Tuberculosis treatment monitoring and outcome measures: new interest and new strategies

J Heyckendorf, SB Georghiou, N Frahm… - Clinical microbiology …, 2022 - Am Soc Microbiol
Despite the advent of new diagnostics, drugs and regimens, tuberculosis (TB) remains a
global public health threat. A significant challenge for TB control efforts has been the …

[HTML][HTML] Blood transcriptomics reveal the evolution and resolution of the immune response in tuberculosis

O Tabone, R Verma, A Singhania… - Journal of Experimental …, 2021 - rupress.org
Blood transcriptomics have revealed major characteristics of the immune response in active
TB, but the signature early after infection is unknown. In a unique clinically and temporally …

A half-century of research on tuberculosis: Successes and challenges

BR Bloom - Journal of Experimental Medicine, 2023 - rupress.org
Great progress has been made over the past half-century, but TB remains a formidable
global health problem, particularly in low-and middle-income countries. Understanding the …

Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?

RR Nathavitharana, AL Garcia-Basteiro, M Ruhwald… - …, 2022 - thelancet.com
Rapid, accurate, sputum-free tests for tuberculosis (TB) triage and confirmation are urgently
needed to close the widening diagnostic gap. We summarise key technologies and review …